MENU
+Compare
OTLK
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$2.23
Change
+$0.04 (+1.83%)
Capitalization
55.54M

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OTLK with price predictions
Jan 08, 2025

Momentum Indicator for OTLK turns positive, indicating new upward trend

OTLK saw its Momentum Indicator move above the 0 level on December 26, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where OTLK's RSI Oscillator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where OTLK advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OTLK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OTLK broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OTLK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). OTLK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OTLK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OTLK is expected to report earnings to rise 22.92% to -98 cents per share on May 15

Outlook Therapeutics OTLK Stock Earnings Reports
Q1'24
Est.
$-0.98
Q4'23
Beat
by $0.19
Q3'23
Missed
by $0.94
Q2'23
Missed
by $1.55
Q1'23
Missed
by $0.54
The last earnings report on February 14 showed earnings per share of -80 cents, beating the estimate of -99 cents. With 1.07M shares outstanding, the current market capitalization sits at 55.54M.
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
485 Route 1 South Building F
Phone
+1 609 619-3990
Employees
24
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGNX7.370.22
+3.08%
REGENXBIO
HTLF65.781.19
+1.84%
Heartland Financial USA
SHFS0.390.01
+1.82%
SHF Holdings
WH103.250.39
+0.38%
Wyndham Hotels & Resorts
GD266.67-0.74
-0.28%
General Dynamics Corp

OTLK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with HEPA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then HEPA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+1.83%
HEPA - OTLK
34%
Loosely correlated
+4.22%
CYTK - OTLK
33%
Loosely correlated
-2.66%
PDSB - OTLK
33%
Loosely correlated
+1.40%
MCRB - OTLK
32%
Poorly correlated
+4.41%
VIR - OTLK
31%
Poorly correlated
+0.60%
More